Compare PTGX & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | CWEN |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.8B |
| IPO Year | 2016 | 2013 |
| Metric | PTGX | CWEN |
|---|---|---|
| Price | $89.29 | $34.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $86.44 | $39.14 |
| AVG Volume (30 Days) | 898.7K | ★ 971.0K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 5.20% |
| EPS Growth | N/A | ★ 125.75 |
| EPS | 0.72 | ★ 2.34 |
| Revenue | $209,217,000.00 | ★ $1,375,000,000.00 |
| Revenue This Year | N/A | $3.65 |
| Revenue Next Year | $296.47 | $14.78 |
| P/E Ratio | $124.48 | ★ $14.44 |
| Revenue Growth | N/A | ★ 0.81 |
| 52 Week Low | $33.70 | $24.40 |
| 52 Week High | $93.25 | $36.89 |
| Indicator | PTGX | CWEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 44.11 |
| Support Level | $83.52 | $34.69 |
| Resistance Level | $90.85 | $36.70 |
| Average True Range (ATR) | 2.63 | 0.73 |
| MACD | -0.33 | -0.41 |
| Stochastic Oscillator | 83.62 | 9.12 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.